Guideline for the treatment of Hansen's disease in Japan (Third edition)-Reference-Cited by-同舟云学术

Guideline for the treatment of Hansen's disease in Japan (Third edition)

Published:2013 Issue:3 Volume:82 Page:143-184
ISSN:1342-3681
Container-title:Japanese journal of leprosy
language:en
Short-container-title:Jpn.J.Leprosy

Author:

Goto Masamichi¹,Nogami Reiko²,Okano Yoshiko³,Gidoh Masaichi⁴,Yotsu Rie⁵,Ishida Yutaka⁶,Kitajima Shinichi⁷,Kai Masanori⁸,Ishii Norihisa⁸,Ozaki Motoaki⁹,Hatano Kentaro³

Affiliation:

1. National Sanatorium Hoshizuka-Keiaien

2. National Kikuchi Keifuen Sanatorium

3. National Sanatorium Oku-Komyoen

4. National Hansen’s Disease Museum

5. National Center for Global Health and Medicine

6. Amakusa City Ushibuka Hospital

7. Department of Pathology, Kagoshima University Hospital

8. Leprosy Research Center, National Institute of Infectious Diseases

9. Department of Dermatology, Kyoto University

Publisher

Japanese Leprosy Association

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/hansen/82/3/82_143/_pdf

Reference67 articles.

1. 13) WHO expert committee on leprosy, eighth report. Technical report series 968, WHO, Geneva, 2012.

2. 14) WHO expert committee on leprosy, seventh report. Technical report series 874, WHO, Geneva, 1998.

3. 16) Ridley DS, Jopling WH: Classification of leprosy according to immunity - A five group system. Int J Lepr 54: 255-273, 1966.

4. 17) Chemotherapy of leprosy for control programmes. WHO Technical report series 675, WHO, Geneva, 1982.

5. 18) WHO expert committee on leprosy, sixth report. WHO Technical report series 768, WHO, Geneva, 1988.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hansen's disease (leprosy) in Japan, 1947-2020: an epidemiologic study during the declining phase to elimination;International Journal of Infectious Diseases;2022-12

2. WHOのハンセン病診断治療予防ガイドライン2018年について;JAPANESE JOURNAL OF LEPROSY;2021

3. Leprosy with spontaneous type 1 lepra reaction as an initial cutaneous manifestation: a case from Japan;European Journal of Dermatology;2018-11

4. Dapsone in Dermatology;Biologic and Systemic Agents in Dermatology;2017-10-06

5. Guideline for clinical use of thalidomide for management of erythema nodosum leprosum in Japan;JAPANESE JOURNAL OF LEPROSY;2017